GlassScriptPhysician profile
Husnu E Kaynak
NPI 1164709929
$31,461.01
in general payments reported to CMS, 2019-2025
26 companies · $8,873 in 2025
The $8,873 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $581 · 2021: $1,909 · 2022: $6,803 · 2023: $7,332 · 2024: $5,496 · 2025: $8,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,848 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Travel and Lodging: $5,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,848.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Travel and Lodging | $5,852.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,473.45 | 2021-2025 | Corevalve Evolut R, Micra, Symplicity G3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7,066.59 | 2019-2025 | Lifevest |
| Abiomed | $4,084.87 | 2020-2025 | Impella |
| Edwards Lifesciences Corporation | $3,333.96 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cordis US Corp. | $2,100.00 | 2022 | |
| Boston Scientific Corporation | $1,998.39 | 2022-2023 | Watchman Flx, Watchman Access System, Watchman |
| Amgen INC. | $840.66 | 2021-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $589.26 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $400.69 | 2022-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $295.72 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $208.09 | 2022-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $145.89 | 2022-2025 | Opsumit, Uptravi |
| Philips North America LLC | $136.42 | 2022-2024 | (Ck4) Mcot |
| Kiniksa Pharmaceuticals, LTD. | $111.44 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $104.10 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.50 | 2021-2024 | Jardiance |
| Astellas Pharma US INC | $94.52 | 2019 | |
| Abbott Laboratories | $89.51 | 2022-2025 | Diamondback Peripheral, Perclose Prostyle, Portico |
| Cardiovascular Systems INC. | $60.22 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $59.58 | 2024 | Assure Wcd |
| Baxter Healthcare | $56.95 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Siemens Medical Solutions USA, INC. | $33.95 | 2020 | |
| Inari Medical, INC. | $26.79 | 2022 | |
| Pfizer INC. | $24.82 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $15.36 | 2019 | |
| Bard Peripheral Vascular, INC. | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Husnu Kaynak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.